Morgan Stanley lowered the firm’s price target on Colgate-Palmolive (CL) to $104 from $111 and keeps an Overweight rating on the shares. The stock was down 4.6% on Friday despite better than expected FY25 EPS guidance following weaker than expected organic sales growth in Q4 and tariffs being officially confirmed, the analyst tells investors. Despite the weaker organic growth in Q4, the firm still sees a path to 4% going forward, which it notes would be at the high-end of peers.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Elon Musk’s X Adds More Companies to Ad-Boycott Lawsuit
- Colgate-Palmolive: Positive Outlook Amid Growth Challenges
- Colgate-Palmolive Surpasses $20 Billion in Sales
- Apple, Intel little changed near noon following earnings: Morning Buzz
- Morning Movers: Apple and Exxon higher following quarterly earnings